Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
British Journal of Sports Medicine|October 22, 2024
Twenty year analysis of professional men's rugby union knee injuries from the English premiership shows high rates and burdenStephen W West, Sam J Hudson, Lindsay Starling, et al.
BMJ Open|December 29, 2017
BRain health and healthy AgeINg in retired rugby union players, the BRAIN Study: study protocol for an observational study in the UKValentina Gallo, Damien McElvenny, Catherine Hobbs, et al.
International Journal of Sports Medicine|June 3, 2020
Returning to Play after Prolonged Training Restrictions in Professional Collision SportsKeith A Stokes, Ben Jones, Mark Bennett, et al.
Blood|April 5, 2017
Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLLPaul M Barr, Jennifer R Brown, Peter Hillmen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 20, 2021
Concussion and long-term cognitive function among rugby players-The BRAIN StudyValentina Gallo, Damien M McElvenny, Giulia Seghezzo, et al.
Blood|March 5, 2016
BRAF inhibition in hairy cell leukemia with low-dose vemurafenibSascha Dietrich, Andreas Pircher, Volker Endris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep SequencingMarina Parry, Matthew Jj Rose-Zerilli, Viktor Ljungström, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 26, 2018
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaJacqueline C Barrientos, Susan O'Brien, Jennifer R Brown, et al.
Blood|June 13, 2015
Recurrent CDKN1B (p27) mutations in hairy cell leukemiaSascha Dietrich, Jennifer Hüllein, Stanley Chun-Wei Lee, et al.
Journal of Medicinal Chemistry|August 23, 2014
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of PlasmodiumR Matthew Cross, David L Flanigan, Andrii Monastyrskyi, et al.
Pageof 11